SLDB
Solid Biosciences Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.90
+0.34%Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- -$0.37
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.38
- EPS estimate
- -$0.46
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +1.9%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $22
- PT range
- $18 – $26
- Analysts
- 5
4 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.46 | -$0.38 | Beat 17.81% | — |
| May 12, 2026 | -$0.40 | -$0.52 | Miss -30.00% | — |
| Mar 19, 2026 | -$0.51 | -$0.50 | Beat 1.96% | — |
| Aug 12, 2025 | -$0.51 | -$0.42 | Beat 17.65% | — |
| May 15, 2025 | -$0.53 | -$0.59 | Miss -11.32% | — |
| Mar 6, 2025 | -$0.79 | -$0.89 | Miss -12.66% | — |
| May 15, 2024 | -$0.57 | -$0.64 | Miss -12.28% | — |
| Mar 13, 2024 | -$1.01 | -$1.00 | Beat 0.99% | $4.7M |
| Nov 8, 2023 | -$1.20 | -$1.05 | Beat 12.50% | — |
| Aug 14, 2023 | -$1.52 | -$1.25 | Beat 17.76% | — |
| May 11, 2023 | -$1.83 | -$1.54 | Beat 15.85% | — |
| Mar 23, 2023 | -$2.70 | -$0.68 | Beat 74.81% | $8.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026